TNFSF10 and neoplasm: Mice bearing tumor xenograft transplants were treated with sorafenib at 30 mg/kg daily for 5 days, Apo2L/TRAIL 100 μg i.v. every two days for 3 doses, or Apo2L/TRAIL receptor-agonist antibodies at 10 mg/kg every two days for 3 doses.